Dr. Navin Kumar Thirugnanasambandam Durairajan, M.D.
What this data tells you about Dr. Thirugnanasambandam Durairajan
Dr. Navin Kumar Thirugnanasambandam Durairajan is a pulmonary disease in Melbourne, FL, with 11 years in practice. Based on federal Medicare data, Dr. Thirugnanasambandam Durairajan performed 660 Medicare services across 446 unique beneficiaries.
Between the years covered by Open Payments, Dr. Thirugnanasambandam Durairajan received a total of $4,467 from 8 pharmaceutical and/or device companies across 39 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Thirugnanasambandam Durairajan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min | 175 | $160 | $499 |
| Office visit, established patient (30-39 min) | 98 | $90 | $210 |
| Hospital follow-up visit, high complexity | 96 | $91 | $210 |
| Hospital follow-up visit, moderate complexity | 77 | $60 | $147 |
| Initial hospital admission, high complexity | 54 | $129 | $403 |
| Office visit, established patient (20-29 min) | 45 | $58 | $145 |
| Test to examine how well the lungs exchange gases | 25 | $7 | $60 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 25 | $14 | $25 |
| Test to determine lung volumes using sensors | 24 | $9 | $70 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 23 | $8 | $53 |
| New patient office visit (45-59 min) | 18 | $125 | $320 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Thirugnanasambandam Durairajan is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Thirugnanasambandam Durairajan experienced with critical care, first 30-74 min?
Does Dr. Thirugnanasambandam Durairajan receive payments from pharmaceutical companies?
How do Dr. Thirugnanasambandam Durairajan's costs compare to other pulmonary diseases in Melbourne?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology